American Herbal Products Association (AHPA) > Resources > Regulations > Government Advocacy

Recent AHPA Advocacy

Dietary Supplements Regulatory Summit

Hosted by AHPA, CHPA, CRN, NPA and UNPA

This one-day regulatory summit will feature updates and insights from FDA and industry regulatory experts, and will focus on the key regulatory compliance issues facing the dietary supplements industry.

IADSA update on international supplement regulations

IADSA February 2018 Newsflash

This issue of the IADSA Newsflash includes an update on France's new maximum levels for vitamins and minerals in supplements

AHPA recommends regulatory improvements in comments submitted to CFSAN

Recommendations seek to reduce regulatory burdens while maintaining consumer protections

The American Herbal Products Association (AHPA) submitted nearly 100 pages of comments today to the Food and Drug Administration (FDA) Center for Food Safety and Applied Nutrition (CFSAN) identifying numerous ways to improve regulations, guidance documents, and enforcement practices to protect public health more effectively and efficiently.
Day on the Hill

Day on the Hill

AHPA partners with CRN to produce this unique advocacy opportunity

AHPA member company executives—including company presidents, regulatory experts, and government relations executives—with a vested interest in legislative activity in Congress—fly in from across the nation, for a full day of networking and discussions with members of Congress and their staff. 
McGuffin statement on Sen. Hatch retirement

McGuffin statement on Sen. Hatch retirement

DSHEA was a remarkable achievement, made possible in large part by Sen. Hatch’s persistence and hard work

American Herbal Products Association (AHPA) President Michael McGuffin issued the following statement regarding the retirement of Sen. Orrin Hatch (R-UT), a vocal dietary supplement advocate who helped shape the laws that regulate the industry.
Industry Coalition Reminds Consumers, Retailers, and Product Marketers that Dietary Supplements Cannot Claim to Treat Opioid Addiction

Industry Coalition Reminds Consumers, Retailers, and Product Marketers that Dietary Supplements Cannot Claim to Treat Opioid Addiction

Industry trade associations have been consistent in taking strong positions against marketing dietary supplements for treatment or prevention of diseases

The dietary supplement industry is aware of growing concerns regarding significant negative health impacts associated with opioid addiction and abuse. The leading trade associations of the dietary supplement industry support the responsible marketing and use of health-promoting vitamins, minerals, herbs, sports nutrition, and other dietary supplements.

AHPA submits comments on pre-DSHEA dietary ingredient list

AHPA recommended that FDA make significant changes to previous positions on new dietary ingredients (NDIs)

AHPA's comments were submitted in response to FDA's request for input on issues related to the future development of a list of dietary ingredients marketed in the United States prior to October 15, 1994, when the Dietary Supplement Health and Education Act (DSHEA) became law.

UNPA endorses AHPA's Good Agricultural and Collection Practices and Good Manufacturing Practices for Botanical Material

UNPA will encourage member companies to adopt AHPA's guidance

UNPA is the most recent association to endorse AHPA's guidance. The guidance has also been endorsed by the Council for Responsible Nutrition (CRN) and Consumer Healthcare Products Association (CHPA).

IADSA update on international supplement regulations

IADSA November 2017 Newsflash

This issue of the IADSA Newsflash includes an overview of Thailand expanding its list of botanicals allowed to be used in supplements, China's plan to take enforcement action against fraudulent and illegal health claims and New Zealand and Australia legalizing hemp seeds as a food.

Dietary Supplement Industry and U.S. Anti-Doping Agency Warn Consumers about Dangerous, Illegal Ingredients Known as SARMs

Groups support strict enforcement action by FDA

The dietary supplement industry’s leading trade associations and the U.S. Anti-Doping Agency (USADA) today joined in support of the U.S. Food and Drug Administration’s (FDA) recent actions to protect consumers from body-building products containing Selective Androgen Receptor Modulators (SARMs) illegally marketed as dietary supplements.

2018 Annual Fund Sponsors


AHPA appreciates the support of its sponsors, but does not endorse, recommend, or provide a warranty for any sponsor company, its products or services. AHPA has no responsibility for any transaction entered into with any of these companies.